Gene Keeps Mouse Bone Stem Cells Supplied

NYU Langone researchers found that the gene HOXA10 protects bone stem cell reserves across a mouse's lifetime.

Updated on Nov. 6, 2026 in Life Sciences

Bold flat-color editorial illustration showing a cluster of glowing green cells beside a bone-shaped silhouette on a cream field, evoking a gene that sustains bone regeneration. — NYU Langone researchers found that the gene HOXA10 keeps mouse bone stem cell reserves supplied throughout life, and that without it bone burns through stem cells too early. AI Illustration. Upload story photo >

Researchers identified the gene HOXA10 as a lifelong protector of bone stem cell supplies in mice, with the findings published online November 4 in Science Advances. Mice lacking HOXA10 action could not heal properly after breaking a bone.

Why it matters

Without HOXA10, bone burns through its stem cell reserves too early, suggesting HOX genes may be potential therapeutic targets for enhancing bone regeneration. The results also indicate human stem cells may depend even more on these genes for long-term self-renewal.

In a 15-month mouse study, 90 percent of expected bone stem cells and their descendants were lost after HOXA10 was deleted, compared with controls, while silencing related HOX genes raised apoptosis in human stem cells by 50 percent. Whether these mouse and cell-culture results translate to human bone repair has not yet been tested.

The players

NYU Langone Health

NYU Langone Health is the academic medical center whose researchers led the study, and it is affiliated with the NYU Grossman School of Medicine.

Science Advances

Science Advances is an open-access peer-reviewed journal published by the American Association for the Advancement of Science, where the study appeared online.

The details

The team genetically engineered mice so HOXA10-expressing stem cells carried a fluorescent green marker and built in mechanisms to switch HOXA10 genes off on command. Deleting the gene caused collagen proteins that form the early framework for bone rebuilding to become disorderly, and the researchers also silenced three related HOX genes in human bone cells.

2023: A prior study led by Dr. Leucht showed increasing HOXA10 activity improved fracture healing in older mice.
November 4, 2026: The study was published online in Science Advances.
Mice were tracked for 15 months after HOXA10 was deleted in 6-day-old pups.

Big Picture

The new work builds on a 2023 study led by Dr. Leucht that found boosting HOXA10 activity improved fracture healing in older mice. By showing that HOXA10 maintains bone stem cell reserves over a lifetime, the research points to the underlying mechanism behind that earlier healing benefit.

If HOX genes prove to be effective targets, future treatments could aim to slow the depletion of bone stem cells that weakens healing in older adults. For now, the findings remain at the laboratory stage in mice and cultured cells, and no clinical therapy is available.

The takeaway

Bone repair depends on keeping stem cell supplies stocked over a lifetime, and HOXA10 appears to be a key gatekeeper. Readers interested in regenerative medicine should watch whether these mouse findings are confirmed in human studies.